A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint

Georgetown University Hospital, Washington D.C.

Wake Forest University, Winston-Salem

Atlanta Colon and Rectal Surgery, Riverdale

University of Miami, Miami

Ohio State University, Columbus

MD Anderson Cancer Center, Houston

University of Colorado Cancer Center, Aurora

Long Beach Memorial Medical Center, Long Beach

Glendale Memorial Hospital, Glendale

Scripps Cancer Center, San Diego

South Orange County Surgical Medical Group, Laguna Hills

Sutter Roseville Medical Center /Research, Roseville

Sutter Cancer Center, Sacramento

UC Davis Cancer Center, Sacramento

Franciscan Research Center, Tacoma

Yale Cancer Center, New Haven

Albert Einstein College of Medicine, Montefiore Medical Center, The Bronx

Landeskrankenhaus Feldkirch, Feldkirch

Krankenhaus der Elisabethinen, Linz

Medical University of Vienna, Vienna

University of Hong Kong/ Queen Mary Hospital, Hong Kong

Odense Universitetshospital, Odense

CRLC Val d'Aurelle-Paul Lamarque, Montpellier

Klinikum Rechts Der Isar, Munich

Matsuda Hospital, Hamamatsu

Medisch Centrum Alkmaar, Alkmaar

Medisch Spectrum Twente, Enschede

Westfriesgasthuis, Hoorn

LUMC, Leiden

Vall d' Hebron University Hospital, Barcelona

IDIBELL Institut Catala d'Oncologia (ICO), L'Hospitalet de Llobregat

Immunology Akademiska sjukhuset/ University Hospital, Uppsala

Kantonsspital Baden, Baden

Norfolk and Norwich University Hospital, Norwich

University of Oxford, Oxford